Edwards’s Konect Resilia, expecting regulatory approval in 2020 [Image from Edwards]
Edwards Lifesciences: Konect Resilia
To dovetail with its TAVR technologies, Edwards Lifesciences is planning to launch its Konect Resilia conduit in 2020.
Konect Resilia is a pre-assembled aortic-valved conduit for use during the Bentall procedure. The device consists of a Carpentier-Edwards Perimount Magna Ease aortic valve stent, Resilia tissue leaflets and a new DualFit sewing ring that is pre-assembled to a Terumo GelWeave Valsalva Graft.
In a study published in the Journal of Cardiovascular Surgery in 2019, the aortic-valved conduit’s handling and implantability were shown to be uniformly satisfactory in human cadaver hearts. The valve was easily extracted surgically and left the conduit and coronary ostia intact, the authors said.
Update: The FDA approved Konect Resilia in July 2020.
